GB2377757A - Tissue clearing solution - Google Patents
Tissue clearing solution Download PDFInfo
- Publication number
- GB2377757A GB2377757A GB0117617A GB0117617A GB2377757A GB 2377757 A GB2377757 A GB 2377757A GB 0117617 A GB0117617 A GB 0117617A GB 0117617 A GB0117617 A GB 0117617A GB 2377757 A GB2377757 A GB 2377757A
- Authority
- GB
- United Kingdom
- Prior art keywords
- aqueous
- clearing solution
- biological
- solution
- clearing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 7
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229960005423 diatrizoate Drugs 0.000 claims abstract description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000008365 aqueous carrier Substances 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 8
- ZEYOIOAKZLALAP-UHFFFAOYSA-M sodium amidotrizoate Chemical compound [Na+].CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I ZEYOIOAKZLALAP-UHFFFAOYSA-M 0.000 claims description 5
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 2
- WSDDJLMGYRLUKR-WUEGHLCSSA-L disodium;[(2r,3r,4r,5r)-2-(6-aminopurin-9-yl)-5-[[[[(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] hydrogen phosphate Chemical compound [Na+].[Na+].NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP([O-])([O-])=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 WSDDJLMGYRLUKR-WUEGHLCSSA-L 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 47
- 239000000243 solution Substances 0.000 description 30
- 210000004556 brain Anatomy 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 241001674044 Blattodea Species 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 241000238791 Diploptera punctata Species 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 3
- 102000002247 NADPH Dehydrogenase Human genes 0.000 description 3
- 108010014870 NADPH Dehydrogenase Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 210000003850 cellular structure Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 210000002686 mushroom body Anatomy 0.000 description 3
- 210000004179 neuropil Anatomy 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000238814 Orthoptera Species 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 238000000339 bright-field microscopy Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000004624 confocal microscopy Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 241000238818 Acheta domesticus Species 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- NPRJSFWNFTXXQC-QFWQFVLDSA-N N-(hexanoyl)sphing-4-enine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCC NPRJSFWNFTXXQC-QFWQFVLDSA-N 0.000 description 1
- HZIRBXILQRLFIK-VPZZKNKNSA-N N-{6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl}sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCCNC1=CC=C([N+]([O-])=O)C2=NON=C12 HZIRBXILQRLFIK-VPZZKNKNSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-J NADPH(4-) Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OC[C@@H]2[C@H]([C@@H](OP([O-])([O-])=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-J 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ACFIXJIJDZMPPO-UHFFFAOYSA-N beta-NADPH Natural products C1=CCC(C(=O)N)=CN1C1C(O)C(O)C(COP(O)(=O)OP(O)(=O)OCC2C(C(OP(O)(O)=O)C(O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000010226 confocal imaging Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- HZIRBXILQRLFIK-IEECYHMASA-N n-[(e,2s,3s)-1,3-dihydroxyoctadec-4-en-2-yl]-6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanamide Chemical compound CCCCCCCCCCCCC\C=C\[C@H](O)[C@H](CO)NC(=O)CCCCCNC1=CC=C([N+]([O-])=O)C2=NON=C12 HZIRBXILQRLFIK-IEECYHMASA-N 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Biological tissue samples are made transparent by treating with an aqueous clearing solution. The solution may comprise dimethyl sulfoxide, diatrizoate acid or it's sodium salt, EDTA, glucamine, NADP and/or a polyoxyalkylene derivative such as Tween (RTM) in an aqueous carrier.
Description
<Desc/Clms Page number 1>
AN AQUEOUS TISSUE CLEARING SOLUTION
FIELD OF THE INVENTION
The invention relates to a solution used in analysis of biological tissues and, more particularly, to the composition of an aqueous clearing solution making biological tissues transparent.
BACKGROUND OF THE INVENTION
For some lift sciences such as cell biology, neurobiology, molecular biology, physiology, immunology, signal biology, and development biology, to examine biological or non-biological planar or three-dimensional microscopic structures, in addition to having a good microscope such as a confocal microscope to obtain high-resolution images, it is also necessary to specially take care of preparation of samples, recording of microscopic images, and processing of images so that optics can be exploited to examine some samples and biological cells or tissues capable of emitting fluorescence. When preparing samples, it is necessary to assure the wholeness of three-dimensional structures of the samples in the processing procedure such as the fixation or mounting procedure.
Generally speaking, conventional transmitted light microscopy is extensively used in almost every biological laboratory for observation of cellular structures. Biological tissues are usually stained with dyes before they can be examined with microscopy. To view the stained internal structures, tissues are usually sectioned into thin slices. In order to increase tissue transparency, most preparations of stained samples are cleared by dehydration
<Desc/Clms Page number 2>
and lipid extraction processes. For example, xylene is often used to clear paraffin sections after alcohol dehydration. As a result, the stained internal features can be sharply focused.
However, solvent extraction requires more processing time and often causes morphology distortion and needs to be avoided in some situations. For example, cryosectionings performed for rapid diagnosis purpose are usually not fixed well. These tissue slices are usually embedded directly in glycerol-based aqueous mountant without clearing process to avoid destruction of the fragile morphology. The resulting microscopic images are thus suffered from decrease of clarity. Moreover, during the processes of examination, scanning, and image reconstruction of biological tissues, the reconstructed thickness can only reach
100-200 micrometers due to not good transparency of tissue samples.
Accordingly, the present invention proposes an aqueous clearing solution to effectively make biological tissues transparent without damaging tissues and without dehydration process. Figs. 1A to 1 C demonstrate that an insect brain of about 500 11m thick that is normally opaque in saline (Fig. IA), semi-opaque in 80% glycerol-saline mixture (Fig. IB) and completely transparent in the invented clearing solution (Fig. 1 C).
SUMMARY OF THE INVENTION
The primary object of the present invention is to provide an aqueous tissue clearing solution making biological tissues transparent without dehydration process.
Another object of the present invention is to provide a method to process biological tissue processed by an aqueous tissue clearing solution to obtain
<Desc/Clms Page number 3>
images of higher resolution in fluorescent and non-fluorescent light microscopes.
Yet another object of the present invention is to provide an aqueous tissue clearing solution to make tissues transparent without damaging slices and detailed morphology of tissues.
To achieve the above objects, an aqueous tissue clearing solution of the present invention comprises one or more of dimethyl sulfoxide, diatrizoate acid, ethylenediaminetetraacetic acid, glucamine, ss-nicotinamide adenine dinucleotide phosphate, sodium diatrizoate, and derivative of polyoxyalkalene (with a trade name of Tween 20 and used as emulsifying agent and detergent) in a suitable aqueous solution. This aqueous tissue clearing solution is utilized to make tissues transparent.
BRIEF DESCRIPTION OF THE DRAWINGS : Figs. 1A to 1 C show evaluation of tissue transparency. Brain tissues of about 500 u. m thick are derived from the cockroach, Diploptera punctata, adult females. (A) The brain is opaque when incubated in the cockroach physiological saline solution. (B) The brain is semi-transparent in saline solution containing 80% glycerol. (C) The brain becomes completely transparent in the invented aqueous clearing solution.
Figs. 2A and 2B show effects of tissue transparency on confocal imaging.
Confocal image series of antennal glomeruli of the cockroach, D. punctata are taken at every 50u. m Z-intervals. (A) The internal glomeruli become invisible at depth of 100 um beneath the surface of the tissue when embedded in saline solution containing 80% glycerol. (B) The image of glomeruli remains clear
<Desc/Clms Page number 4>
even at 200 um depth when embedded in the invented aqueous clearing solution.
Fig. 3 shows a three-dimensional map of brain neuropils of the cockroach, Diploptera punctata adult female.
Fig. 4 shows a microscopic image of the mushroom bodies in a transparent cricket brain observed under a general transmitted light microscope.
Fig. 5 shows a high-resolution confocal image of human fibroblasts embedded in the invented aqueous clearing solution.
Fig. 6 shows a three-dimensional reconstruction of the pollen grain about 100 u. m in diameter. The distance from each structure to the surface is indicated by color gradients.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention relates to an aqueous tissue clearing solution for use in making tissues transparent. The aqueous tissue clearing solution of the present invention comprises one or more of dimethyl sulfoxide, diatrizoate acid, ethylenediaminetetraacetic acid, glucamine, ss-nicotinamide adenine dinucleotide phosphate, sodium diatrizoate, and derivative of polyoxyalkalene (with a trade name of Tween 20 and used as emulsifying agent and detergent) in a suitable aqueous solution. The pH value of the above solution is adjusted to the range of 5-10.
The above tissues comprise biological structures such as animal and plant cells, biological organisms, and biological compounds and devices.
Transparency can be achieved by direct incubation of the tissue in the invented clearing solution with or without prior fixation. A biological tissue
<Desc/Clms Page number 5>
having a better transparency is obtained after an incubation period. When a specific internal structure of interest is labeled with immunofluorescence or classical dyes, making transparency of components above and bellow the labeled object results in better imaging and higher detection sensitivity of the stained structure. Thus, making transparency with the invented aqueous clearing solution will enhance the observation and signal detection of fluorescent and non-fluorescent cellular structures during the application of optical detection methods such as confocal microscopy, fluorescence microscopy, conventional transmitted light microscopy, dissecting microscopy, flow cytometry, spectrophotometry, fluorescence plate detection and fluorescence chip detection, etc. The transparency achieved by using the aqueous tissue clearing solution of the present invention can enhance observation capability and signal detection sensitivity of fluorescent and nonfluorescent cellular structures.
Confocal microscopy offers the possibility of removing out-of-focus background fluorescence in a fluorescently labeled thick specimen and recording the X, Y and Z coordinates of objects that then can be rendered and analyzed three-dimensionally. Opacity of biological tissues thicker than 100 u. m, about 5-10 cells thickness, normally prevents efficient excitation and sufficient signal strength for fluorescence detection. On the other hand, routine methods using serial alcohol dehydration and methyl salicylate-permeated clearing often result in diffusion of the labeled fluorochromes. Clearing and embedding the fluorochrome-labeled tissues in the invented clearing solution largely overcome these problems. For example, when embedded in 80%
<Desc/Clms Page number 6>
glycerol-saline mixture, the glomeruli within an insect's antennal lobe can only be confocally viewed up to 100 11m below the surface (Fig. 2A). In contrast, the internal structures deeper than 200 11m can still be clearly viewed when the sample is cleared and embedded in the invented aqueous clearing solution (Fig.
2B). Furthermore, the fluorescence NBD-ceramide, the membrane probe used for staining all lipophilic structures within biological tissues, will be gradually dissolved in glycerol-saline mixture. As a result, details of the labeled fine structures are no longer visible. In contrast, those details remain clear when the same tissue is embedded in the invented aqueous clearing solution.
The present invention will be illustrated by describing the following examples.
EXAMPLE 1 : Microscopic imaging of thick tissues labeled with fluorescent probes.
An insect brain, more than 500 11m thick, of the cockroach Diploptera punctata is used for the demonstration. Neuropil structures and neuronal somata within the brain were stained with the lipophilic membrane probe NBD
C6-ceramide and DNA-probe propidium iodide. After proper fixation in 4% paraformaldehyde, nuclei within the brains were digested with 50 ug/ml RNase and stained with 2011g/ml propidium iodide in phosphate buffered saline. Subsequently, after briefly rinsed in phosphate buffered saline, membranes were stained with 0.435mM NBD C6-ceramide in DMSO. The brain was making transparent by direct incubation in the invented clearing solution for one hour. To avoid compression under the coverslip, specimen were placed within spacer rings approximately 600lem in height and then subjected for
<Desc/Clms Page number 7>
confocal microscope imaging. The fluorescent structures within the entire brain can then be directly observed under a conventional fluorescence microscope or imaged with a confocal microscope. Fig. 3 shows a three-dimensional cockroach brain containing all internal neuropils reconstructed from computer- segmented images of 168 confocal optical slices. This would not be possible if the brain tissue is not transparent enough for laser penetration and fluorescence detection.
In addition to making whole-mount tissue transparent, the invented clearing solution can be also applied for tissue slices such as cryosections and vibratome slices.
EXAMPLE 2 Microscopic imaging of thick tissues labeled with nonfluorescent dyes.
The brain of the cricket, Acheta domesticus, is used for the demonstration.
The brain was fixed in 4% paraformaldehyde in phosphate buffered saline (360 mOsM per Kg H2O, pH 7.4) on ice for 2 hours. They were then washed 3 times in ice-cold PBS, 10 min each wash. The tissues were permeabilized by incubating them for 16 h at 4 C in phosphate buffered saline containing 1% Triton X-100. After being washed with phosphate buffered saline, fixationinsensitive NADPH-diaphorase activity was visualized by incubating the tissues at 27 C for 2 hours in lOOu ! Tris-HCI (50mM, pH 7.4) containing 1%
Triton X-100, ImM ss-NADPH and 0. 5mM NBT. Blue formazan precipitates out of the solution and, in so doing, indicates sites where NADPH-diaphorase has reacted. Non-specific background precipitation was removed by extensive washing of tissues for 72 hours in Tris-HCI buffer containing 1% Triton X-100.
<Desc/Clms Page number 8>
After cleaning the surrounding connective tissues, the entire brain of more than zum thick was making transparent by direct incubation in the invented aqueous clearing solution for one hour. To avoid compression under the coverslip, specimen were placed within spacer rings mounted in the same aqueous clearing solution, viewed and photographed the tissue under a dissecting microscopy or with a Zeiss Axiophot (Carl Zeiss, Jena, Germany) compound microscope using Nomarski optics. Fig. 4 shows that high NADPHdiaphorase activity indicated with formazan precipitates occurred at the mushroom bodies. The internal mushroom bodies can be clearly viewed because the brain is made transparent by incubation in the invented clearing solution.
This method can be also applied for viewing structures within tissues slices derived from cryosections and vibratome slices labeled with non-fluorescent dyes.
EXAMPLE 3 Microscopic imaging of single cells labeled with fluorescent or non-fluorescent probes.
Fixed single cells on the slides can be directly cleared and mounted in the invented clearing solution. The aqueous nature of the clearing solution allows its direct usage for immunofluorescence-or other fluorochrome-labeled single cells. Fig. 5 shows that high degree of transparency largely improves the resolution and sensitivity for image detection using confocal microscope.
Because of the improved transparency, excitation efficiency and emission detection sensitivity are greatly increased. Therefore, application of smaller pinhole for removing out-of-focus background fluorescence can be applied.
<Desc/Clms Page number 9>
This method can be also applied for viewing single cells labeled with non-fluorescence dyes with conventional microscope. It is also effective for tissues with autofluorescence such as Drosophila mutants expressing green fluorescence proteins or plant tissues. Fig. 6 shows a three-dimensional reconstruction of an autofluorescent pollen grain about 100 Mm in diameter.
The surface morphology with depth code is rendered from a stack of confocal optical sections at 5-micrometer intervals.
Although the present invention has been described with reference to the preferred embodiments thereof, it will be understood that the invention is not limited to the details thereof. Various substitutions and modifications have been suggested in the foregoing description, and others will occur to those of ordinary skill in the art. Therefore, all such substitutions and modifications are intended to be embraced within the scope of the invention as defined in the appended claims.
Claims (21)
1. An aqueous clearing solution for use in increasing the transparency of biological tissues, composition of said clearing solution comprising one or more of dimethyl sulfoxide, diatrizoate acid, ethylenediaminetetraacetic acid, glucamine, ss-nicotinamide adenine dinucleotide phosphate, sodium diatrizoate, and derivative of polyoxyalkalene, said composition being placed in a suitable aqueous carrier therefor.
2. The aqueous clearing solution as claimed in claim 1, wherein said biological tissues comprise animal and plant cells.
3. The aqueous clearing solution as claimed in claim 1, wherein said biological tissues comprise biological organisms.
4. The aqueous clearing solution as claimed in claim 1, wherein said biological tissues comprise biological compounds and devises.
5. The aqueous clearing solution as claimed in claim 1 that is buffered to a pH from 5 to 10.
6. The aqueous clearing solution as claimed in claim 1 further comprising an excess of sodium diatrizoate and diatrizoate acid.
7. The aqueous clearing solution as claimed in claim 1 further comprising an excess ofDMSO.
8. A method for increasing the transparency of biological tissues to obtain a clear and transparent biological tissue sample after said biological tissue is processed by an aqueous tissue clearing solution.
9. A method as claimed in claims 8, wherein said sample can be examined by a confocal microscope.
<Desc/Clms Page number 11>
10. A method as claimed in claims 8, wherein said sample can be examined by a light microscope.
11. A method as claimed in claims 8, wherein said sample can be examined by a flow cytometer.
12. A method as claimed in claims 8, wherein said sample can be directly observed with eyes or a dissecting microscope.
13. A method of examining biological tissues, comprising the steps of : processing a biological tissue using an aqueous tissue clearing solution to obtain a clean and transparent biological tissue sample; and using a microscope to examine said sample to obtain an internal structural image of said sample.
14. The method as claimed in claim 13, wherein said microscope is a confocal microscope.
15. The method as claimed in claim 13, wherein said microscope is a light microscope.
16. An aqueous clearing solution with clearing composition placed in a suitable aqueous carrier therefor to increase the transparency of biological tissues.
17. The aqueous clearing solution as claimed in claim 16, wherein said clearing composition of said aqueous clearing solution comprises one or more of dimethyl sulfoxide, diatrizoatc acid, ethylcncdiaminctctraacetic acid. glucamine. ss-nicotinamide adenine dinucleotide phosphate, sodium diatrizoate. and derivative of polyoxyalka1cne.
<Desc/Clms Page number 12>
18. An aqueous cleaning solution substantially as described herein tn with reference to the Examples.
19. An aqueous cleaning solution substantially as described herein with reference to the drawings.
20. A method for increasing the transparency of biological tissues substantially as described herein with reference to the Examples.
21. A method for increasing the transparency of biological tissues c substantially as described herein with reference to the drawings.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0117617A GB2377757B (en) | 2001-07-19 | 2001-07-19 | An aqueous tissue clearing solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0117617A GB2377757B (en) | 2001-07-19 | 2001-07-19 | An aqueous tissue clearing solution |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB0117617D0 GB0117617D0 (en) | 2001-09-12 |
| GB2377757A true GB2377757A (en) | 2003-01-22 |
| GB2377757B GB2377757B (en) | 2004-11-17 |
Family
ID=9918807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0117617A Expired - Lifetime GB2377757B (en) | 2001-07-19 | 2001-07-19 | An aqueous tissue clearing solution |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2377757B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015028453A1 (en) * | 2013-08-26 | 2015-03-05 | Leica Microsystems Cms Gmbh | Method and device for increasing the optical transparency of regions of a tissue sample |
| EP2950077A4 (en) * | 2013-01-28 | 2016-11-02 | Japan Science & Tech Agency | METHOD FOR MAKING TRANSPARENT TISSUE, REAGENT FOR MAKING TRANSPARENT TISSUE, AND METHOD FOR OBSERVING TISSUE |
| WO2018100089A1 (en) * | 2016-12-01 | 2018-06-07 | Norbert Gretz | Means and methods for visualization of tissue structures |
| WO2018113723A1 (en) * | 2016-12-22 | 2018-06-28 | The University Of Hong Kong | Compositions and methods for clearing tissue |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111458334B (en) * | 2020-04-16 | 2022-12-06 | 云南大学 | Visualization method for lymphatic vessels in light-color antennae of insects |
| CN113640520A (en) * | 2021-07-16 | 2021-11-12 | 南方医科大学珠江医院 | Application of tissue transparency method and histology method in combination for detecting bacteria in tumor |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981610A (en) * | 1986-05-21 | 1991-01-01 | Universite De Nancy I | Reagent for rendering biological media transparent and its analytical applications |
| EP0822403A1 (en) * | 1996-08-02 | 1998-02-04 | Milestone S.r.l. | Process for processing organic specimens |
| WO1998015831A1 (en) * | 1996-10-10 | 1998-04-16 | University Of British Columbia | Optical quantification of analytes in membranes |
| WO2000020846A1 (en) * | 1998-10-02 | 2000-04-13 | Rogers Imaging Corporation | Method for imaging tissue |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6219575B1 (en) * | 1998-10-23 | 2001-04-17 | Babak Nemati | Method and apparatus to enhance optical transparency of biological tissues |
-
2001
- 2001-07-19 GB GB0117617A patent/GB2377757B/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981610A (en) * | 1986-05-21 | 1991-01-01 | Universite De Nancy I | Reagent for rendering biological media transparent and its analytical applications |
| EP0822403A1 (en) * | 1996-08-02 | 1998-02-04 | Milestone S.r.l. | Process for processing organic specimens |
| WO1998015831A1 (en) * | 1996-10-10 | 1998-04-16 | University Of British Columbia | Optical quantification of analytes in membranes |
| WO2000020846A1 (en) * | 1998-10-02 | 2000-04-13 | Rogers Imaging Corporation | Method for imaging tissue |
Non-Patent Citations (2)
| Title |
|---|
| Biosis AN No. 199800232041 & Biotechnic and Histochemistry 1998, Vol. 73, No. 1, pages 1 - 5. * |
| Neuroscience 1985, Vol. 16, No. 2, pages 461 - 475. * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2950077A4 (en) * | 2013-01-28 | 2016-11-02 | Japan Science & Tech Agency | METHOD FOR MAKING TRANSPARENT TISSUE, REAGENT FOR MAKING TRANSPARENT TISSUE, AND METHOD FOR OBSERVING TISSUE |
| US12474239B2 (en) | 2013-01-28 | 2025-11-18 | Japan Science And Technology Agency | Method for rendering tissue transparent, reagent for rendering tissue transparent, and tissue observation method |
| WO2015028453A1 (en) * | 2013-08-26 | 2015-03-05 | Leica Microsystems Cms Gmbh | Method and device for increasing the optical transparency of regions of a tissue sample |
| US10151675B2 (en) | 2013-08-26 | 2018-12-11 | Leica Microsystems Cms Gmbh | Method and device for increasing the optical transparency of regions of a tissue sample |
| WO2018100089A1 (en) * | 2016-12-01 | 2018-06-07 | Norbert Gretz | Means and methods for visualization of tissue structures |
| WO2018113723A1 (en) * | 2016-12-22 | 2018-06-28 | The University Of Hong Kong | Compositions and methods for clearing tissue |
| CN110139922A (en) * | 2016-12-22 | 2019-08-16 | 香港大学 | For removing the composition and method of tissue |
| CN110139922B (en) * | 2016-12-22 | 2021-05-25 | 香港大学 | Compositions and methods for clarifying tissue |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2377757B (en) | 2004-11-17 |
| GB0117617D0 (en) | 2001-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6472216B1 (en) | Aqueous tissue clearing solution | |
| Zucker et al. | Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy | |
| US6187289B1 (en) | Acetic acid as a contrast in reflectance confocal imaging of tissue | |
| Zucker et al. | Confocal laser scanning microscopy of apoptosis in organogenesis‐stage mouse embryos | |
| JP4095248B2 (en) | Microscope slide | |
| Zucker | Whole insect and mammalian embryo imaging with confocal microscopy: morphology and apoptosis | |
| Luttmer et al. | Examination of living and fixed gametes and early embryos stained with supravital fluorochromes (Hoechst 33342 and 3, 3′‐dihexyloxacarbocyanine iodide) | |
| US20170108414A1 (en) | High-resolution three-dimensional imaging of mammalian hearts | |
| Singh et al. | Confocal microscopy: a powerful technique for biological research | |
| JP2003066035A (en) | Water-soluble tissue clear solution | |
| WO2021023289A1 (en) | Composition and method for rendering biological material | |
| Sam-Yellowe et al. | New trichrome stains identify cysts of Colpodella sp.(Apicomplexa) and Bodo caudatus | |
| GB2377757A (en) | Tissue clearing solution | |
| Zucker et al. | Confocal laser scanning microscopy morphology and apoptosis in organogenesis-stage mouse embryos | |
| Singh | Microscopes in conservative dentistry and endodontics research | |
| Buttino et al. | Use of the confocal laser scanning microscope in studies on the developmental biology of marine crustaceans | |
| Zucker et al. | Utility of fluorescence microscopy in embryonic/fetal topographical analysis | |
| Jones | Papanicolaou staining of air‐dried smears: value in rapid diagnosis | |
| Zucker et al. | Confocal laser scanning microscopy of morphology and apoptosis in organogenesis-stage mouse embryos | |
| Woodland et al. | Sensitivity of immunoperoxidase and immunofluorescence staining for detecting chlamydia in conjunctival scrapings and in cell culture. | |
| Sajadi et al. | The modified method of luxol fast blue for paraffin-embedded myelin sheath staining | |
| Belini et al. | Label-free darkfield-based technique to assist in the detection of Giardia cysts | |
| Chen et al. | Use of a fluorescent membrane probe to identify zooxanthellae in hospite among dissociated endoderm cell culture from coral | |
| Mekuria et al. | Basic Principles and Applications of Live Cell Microscopy Techniques: A Review | |
| Susaki | Basics and applications of tissue clearing technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE20 | Patent expired after termination of 20 years |
Expiry date: 20210718 |